BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19458910)

  • 1. Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID.
    Karaca NE; Aksu G; Genel F; Gulez N; Can S; Aydinok Y; Aksoylar S; Karaca E; Altuglu I; Kutukculer N
    Clin Exp Med; 2009 Dec; 9(4):339-42. PubMed ID: 19458910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.
    de Villartay JP; Lim A; Al-Mousa H; Dupont S; Déchanet-Merville J; Coumau-Gatbois E; Gougeon ML; Lemainque A; Eidenschenk C; Jouanguy E; Abel L; Casanova JL; Fischer A; Le Deist F
    J Clin Invest; 2005 Nov; 115(11):3291-9. PubMed ID: 16276422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of mutations and recombination activity in RAG-deficient patients.
    Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
    Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A variant of SCID with specific immune responses and predominance of gamma delta T cells.
    Ehl S; Schwarz K; Enders A; Duffner U; Pannicke U; Kühr J; Mascart F; Schmitt-Graeff A; Niemeyer C; Fisch P
    J Clin Invest; 2005 Nov; 115(11):3140-8. PubMed ID: 16211094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency.
    Wada T; Toma T; Okamoto H; Kasahara Y; Koizumi S; Agematsu K; Kimura H; Shimada A; Hayashi Y; Kato M; Yachie A
    Blood; 2005 Sep; 106(6):2099-101. PubMed ID: 15845893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.
    Meshaal SS; El Hawary RE; Abd Elaziz DS; Eldash A; Alkady R; Lotfy S; Mauracher AA; Opitz L; Pachlopnik Schmid J; van der Burg M; Chou J; Galal NM; Boutros JA; Geha R; Elmarsafy AM
    Clin Exp Immunol; 2019 Feb; 195(2):202-212. PubMed ID: 30307608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leaky RAG Deficiency in Adult Patients with Impaired Antibody Production against Bacterial Polysaccharide Antigens.
    Geier CB; Piller A; Linder A; Sauerwein KM; Eibl MM; Wolf HM
    PLoS One; 2015; 10(7):e0133220. PubMed ID: 26186701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three faces of recombination activating gene 1 (RAG1) mutations.
    Patiroglu T; Akar HH; Van Der Burg M
    Acta Microbiol Immunol Hung; 2015 Dec; 62(4):393-401. PubMed ID: 26689875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics of human recombination activating gene 1 mutations in 8 immunodeficiency patients with diverse phenotypes].
    Yu G; Wang WJ; Liu DR; Tao ZF; Hui XY; Hou J; Sun JQ; Wang XC
    Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):186-191. PubMed ID: 29518828
    [No Abstract]   [Full Text] [Related]  

  • 10. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.
    Lee YN; Frugoni F; Dobbs K; Walter JE; Giliani S; Gennery AR; Al-Herz W; Haddad E; LeDeist F; Bleesing JH; Henderson LA; Pai SY; Nelson RP; El-Ghoneimy DH; El-Feky RA; Reda SM; Hossny E; Soler-Palacin P; Fuleihan RL; Patel NC; Massaad MJ; Geha RS; Puck JM; Palma P; Cancrini C; Chen K; Vihinen M; Alt FW; Notarangelo LD
    J Allergy Clin Immunol; 2014 Apr; 133(4):1099-108. PubMed ID: 24290284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
    IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Large Cohort of RAG1/2-Deficient SCID Patients-Clinical, Immunological, and Prognostic Analysis.
    Greenberg-Kushnir N; Lee YN; Simon AJ; Lev A; Marcus N; Abuzaitoun O; Somech R; Stauber T
    J Clin Immunol; 2020 Jan; 40(1):211-222. PubMed ID: 31838659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review.
    Kalman L; Lindegren ML; Kobrynski L; Vogt R; Hannon H; Howard JT; Buckley R
    Genet Med; 2004; 6(1):16-26. PubMed ID: 14726805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly variable clinical phenotypes of hypomorphic RAG1 mutations.
    Avila EM; Uzel G; Hsu A; Milner JD; Turner ML; Pittaluga S; Freeman AF; Holland SM
    Pediatrics; 2010 Nov; 126(5):e1248-52. PubMed ID: 20956421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypomorphic RAG1 mutations and CMV infection: a new phenotype of severe combined immunodeficiency].
    Le Deist F; de Villartay JP; Lim A; Déchanet J; Fischer A
    Med Sci (Paris); 2006 Mar; 22(3):239-40. PubMed ID: 16527199
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Manifestations, Mutational Analysis, and Immunological Phenotype in Patients with RAG1/2 Mutations: First Cases Series from Mexico and Description of Two Novel Mutations.
    Lugo-Reyes SO; Pastor N; González-Serrano E; Yamazaki-Nakashimada MA; Scheffler-Mendoza S; Berron-Ruiz L; Wakida G; Nuñez-Nuñez ME; Macias-Robles AP; Staines-Boone AT; Venegas-Montoya E; Alaez-Verson C; Molina-Garay C; Flores-Lagunes LL; Carrillo-Sanchez K; Niemela J; Rosenzweig SD; Gaytan P; Yañez JA; Martinez-Duncker I; Notarangelo LD; Espinosa-Padilla S; Cruz-Munoz ME
    J Clin Immunol; 2021 Aug; 41(6):1291-1302. PubMed ID: 33954879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation.
    van der Burg M; van Veelen LR; Verkaik NS; Wiegant WW; Hartwig NG; Barendregt BH; Brugmans L; Raams A; Jaspers NG; Zdzienicka MZ; van Dongen JJ; van Gent DC
    J Clin Invest; 2006 Jan; 116(1):137-45. PubMed ID: 16357942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative CD4 lymphopenia and a skewed memory phenotype are the main immunologic abnormalities in a child with Omenn syndrome due to homozygous RAG1-C2633T hypomorphic mutation.
    McCusker C; Hotte S; Le Deist F; Hirschfeld AF; Mitchell D; Nguyen VH; Gagnon R; Mazer B; Turvey SE; Jabado N
    Clin Immunol; 2009 Jun; 131(3):447-55. PubMed ID: 19246248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia.
    Alsmadi O; Al-Ghonaium A; Al-Muhsen S; Arnaout R; Al-Dhekri H; Al-Saud B; Al-Kayal F; Al-Saud H; Al-Mousa H
    BMC Med Genet; 2009 Nov; 10():116. PubMed ID: 19912631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel RAG1 mutation and the occurrence of mycobacterial and Chromobacterium violaceum infections in a case of leaky SCID.
    Khan TA; Iqbal A; Rahman H; Cabral-Marques O; Ishfaq M; Muhammad N
    Microb Pathog; 2017 Aug; 109():114-119. PubMed ID: 28552805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.